Exploring Predictive Modeling Algorithms for Good Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Secondary Analysis of a Cluster Randomized Trial Cohort Further Explored by Sex
Health Science Reports · 2026-11 · 9 (11)
DOI: 10.1002/hsr2.73465 ↗Abstract
ABSTRACT Background and Aims Predictive modeling algorithms show promise in identifying risk factors influencing clinical outcomes. This study aims to evaluate different machine learning algorithms to identify an accurate predictive model of glycemic control at 18‐months follow‐up in type 2 diabetes mellitus (T2DM) patients and explore sex‐specific risk factors. Methods Data of T2DM patients from the INTEGRATE dataset (2016–2019) were used. Baseline demographic, anthropometric, clinical biomarkers, and Charlson Comorbidity Index (CCI) were included to develop predictive models using LASSO logistic regression, CART, XGBoost, and Random Forest. Model discrimination was assessed using the area under the curve (AUC), calibration using calibration intercept, slope, and Brier score, clinical utility using decision‐curve analysis (DCA), and model interpretability using SHapley Additive exPlanations (SHAP). Sex‐specific predictors were identified by training separate LASSO models independently within each sex stratum. Results Participants ( n = 4821) had a mean age of 65.4±12.8 years, BMI of 31.4 ± 6.7 kg/m 2 , and 46.6% were female. The predictive models had an AUC of 0.68–0.71, with broadly acceptable calibration across all models. Decision‐curve analysis demonstrated net benefit over treat‐all and treat‐none strategies across clinically plausible threshold probabilities (10%–50%). Insulin use was the strongest predictor of poor glycemic control (HbA1c ≥ 7.0%) in both sexes (males: −2.46, 95% CI: −2.91 to −1.96; females: −2.10, 95% CI: −2.67 to −1.64). SHAP analysis confirmed diabetes medication intensity as the dominant predictor. Sex‐specific predictors included higher HDL in males, and severe comorbidity index in females, although estimates were imprecise. Conclusion LASSO logistic regression and XGBoost showed the highest discrimination (AUC: 0.71) with broadly acceptable calibration. Decision‐curve analysis supported clinical utility across plausible threshold probabilities. SHAP analysis confirmed diabetes medication intensity as the dominant predictor, consistent with sex‐stratified findings. External validation in independent cohorts remains necessary before clinical implementation.
EUVIMED